Resumo

TENESACA, Tania Milena Calle  e  MONTESINOS, Carlos Enrique Flores. Comparação: paracetamol vs ibuprofeno para o tratamento de sintomas em pacientes com infecção por SARS-CoV-2. Vive Rev. Salud [online]. 2023, vol.6, n.16, pp.231-239.  Epub 14-Fev-2023. ISSN 2664-3243.  https://doi.org/10.33996/revistavive.v6i16.221.

The spread of COVID-19 was expeditious and after several reports the efficacy of some non-steroidal anti-inflammatory drugs, such as ibuprofen, was under suspicion. While paracetamol (acetaminophen) was suggested as a safe and recommended alternative for early and home management of pain and fever in patients. Objective. To compare the use of acetaminophen vs ibuprofen for symptom management in patients with SARS-COV-2 infection". Methodology. The research is a systematic review, where scientific articles published in journals related to health areas, available in search engines and digital platforms such as Scienedirect, Pubmed, Elsevier and Springer Link, were analyzed. Searches were performed using previously defined keywords. Conclusion. The use of ibuprofen has been in question since its inception in patients with COVID-19. However, no study claims to associate its use with significant increases in hospital stay, ICU admissions, need for mechanical ventilation, or mortality. However, acetaminophen has been used from the beginning, its use was not in doubt, but recent findings seem to indicate that it is not as effective as originally thought. It is quite inferior in direct comparison with ibuprofen.

Palavras-chave : Acetaminophen; Efficacy; Ibuprofen; Disease Management.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )